Parkside Investments LLC lowered its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 9.6% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 84,247 shares of the exchange traded fund’s stock after selling 8,924 shares during the quarter. SPDR S&P Biotech ETF accounts for about 1.3% of Parkside Investments LLC’s holdings, making the stock its 24th biggest holding. Parkside Investments LLC’s holdings in SPDR S&P Biotech ETF were worth $10,272,000 at the end of the most recent quarter.
Several other institutional investors have also added to or reduced their stakes in XBI. Legacy Wealth Managment LLC ID purchased a new stake in SPDR S&P Biotech ETF during the 4th quarter valued at $32,000. Ballast Advisors LLC purchased a new stake in SPDR S&P Biotech ETF during the 4th quarter valued at $36,000. Creative Financial Designs Inc. ADV purchased a new stake in SPDR S&P Biotech ETF during the 4th quarter valued at $39,000. Barnes Dennig Private Wealth Management LLC purchased a new stake in SPDR S&P Biotech ETF during the 4th quarter valued at $48,000. Finally, Navalign LLC purchased a new stake in SPDR S&P Biotech ETF during the 4th quarter valued at $48,000.
SPDR S&P Biotech ETF Price Performance
Shares of XBI opened at $131.66 on Tuesday. The stock has a market capitalization of $8.40 billion, a P/E ratio of 11.47 and a beta of 0.85. The firm has a fifty day simple moving average of $130.00 and a two-hundred day simple moving average of $125.32. SPDR S&P Biotech ETF has a twelve month low of $78.00 and a twelve month high of $139.19.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
See Also
- Five stocks we like better than SPDR S&P Biotech ETF
- SpaceX Gets the Attention, But These 4 Stocks Could Get the Returns
- Microsoft Stock Discount May Be Ending as AI Catalysts Build
- Apparel Earnings Winners and Losers: Ralph Lauren Takes Off
- Why Walmart, Target and TJX Got Such Different Reactions After Earnings
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
